Research Analysts Set Expectations for Itron FY2027 Earnings

Itron, Inc. (NASDAQ:ITRIFree Report) – Zacks Research lowered their FY2027 EPS estimates for Itron in a note issued to investors on Thursday, January 29th. Zacks Research analyst Team now anticipates that the scientific and technical instruments company will post earnings per share of $6.95 for the year, down from their prior forecast of $6.96. Zacks Research currently has a “Strong Sell” rating on the stock. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron’s Q4 2027 earnings at $1.73 EPS.

ITRI has been the subject of a number of other research reports. Wall Street Zen lowered Itron from a “buy” rating to a “hold” rating in a research note on Wednesday, January 14th. Robert W. Baird reiterated a “neutral” rating and set a $118.00 target price (down from $137.00) on shares of Itron in a research note on Friday, October 31st. Argus reaffirmed a “hold” rating on shares of Itron in a report on Tuesday, November 4th. Johnson Rice upgraded shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective on the stock in a research note on Monday, January 5th. Finally, JPMorgan Chase & Co. upped their target price on shares of Itron from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Thursday, October 16th. Eight analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $136.10.

View Our Latest Stock Report on ITRI

Itron Stock Down 1.1%

Shares of Itron stock opened at $99.08 on Monday. Itron has a 1-year low of $90.11 and a 1-year high of $142.00. The company has a market capitalization of $4.54 billion, a PE ratio of 17.82, a P/E/G ratio of 0.56 and a beta of 1.48. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.17 and a quick ratio of 1.91. The business has a 50-day moving average of $97.30 and a 200-day moving average of $113.44.

Itron (NASDAQ:ITRIGet Free Report) last issued its quarterly earnings data on Thursday, October 30th. The scientific and technical instruments company reported $1.54 EPS for the quarter, topping analysts’ consensus estimates of $1.48 by $0.06. The firm had revenue of $581.63 million for the quarter, compared to analyst estimates of $578.49 million. Itron had a net margin of 10.69% and a return on equity of 17.82%. The firm’s revenue was down 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.84 EPS.

Insider Activity

In other news, SVP Donald L. Reeves III sold 536 shares of the company’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $96.51, for a total transaction of $51,729.36. Following the completion of the transaction, the senior vice president directly owned 19,068 shares of the company’s stock, valued at approximately $1,840,252.68. This represents a 2.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Christopher E. Ware sold 343 shares of the firm’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $33,102.93. Following the completion of the sale, the senior vice president directly owned 18,774 shares in the company, valued at approximately $1,811,878.74. This trade represents a 1.79% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 2,971 shares of company stock valued at $286,731 over the last quarter. Corporate insiders own 1.51% of the company’s stock.

Institutional Investors Weigh In On Itron

Large investors have recently added to or reduced their stakes in the stock. Private Trust Co. NA boosted its holdings in shares of Itron by 112.4% during the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after acquiring an additional 145 shares during the period. Twin Peaks Wealth Advisors LLC bought a new position in Itron in the 2nd quarter worth about $30,000. Employees Retirement System of Texas acquired a new stake in shares of Itron in the third quarter valued at approximately $32,000. Bessemer Group Inc. raised its holdings in shares of Itron by 125.7% during the second quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock valued at $34,000 after buying an additional 142 shares during the last quarter. Finally, Optiver Holding B.V. bought a new stake in shares of Itron during the third quarter valued at approximately $36,000. 96.19% of the stock is owned by institutional investors and hedge funds.

Itron Company Profile

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

See Also

Earnings History and Estimates for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.